Press release
Irritable Bowel Syndrome (IBS) Treatment Market Analysis 2021 Global Insights, Industry Demand, Size, Type, Application, Trends, Outlook 2028
The "Irritable Bowel Syndrome (IBS) Treatment Market Forecast to 2028" is a specialized and in-depth study of the pharmaceutical industry with a special focus on the global market trend analysis. The report aims to provide an overview of Irritable Bowel Syndrome (IBS) Treatment Market with detailed market segmentation by drug type, distribution channel, and geography. The Global Irritable Bowel Syndrome (IBS) Treatment Market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading Irritable Bowel Syndrome (IBS) Treatment Market players and offers key trends and opportunities in the market.The market was valued at US$ 2,153.89 million in 2020 and is projected to reach US$ 4,600.30 million by 2028; it is expected to grow at a CAGR of 10.1% from 2021 to 2028.
Download FREE Sample Report At - https://www.theinsightpartners.com/sample/TIPRE00006814/?utm_source=OpenPR&utm_medium=10741
The report covers key developments in the Irritable Bowel Syndrome (IBS) Treatment Market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from Irritable Bowel Syndrome (IBS) Treatment Market are anticipated to lucrative growth opportunities in the future with the rising demand for Irritable Bowel Syndrome (IBS) Treatment Market in the global market. Below mentioned is the list of few companies engaged in the Irritable Bowel Syndrome (IBS) Treatment Market.
Top Key Players are covered in this report:
• Ironwood Pharmaceuticals, Inc.
• AbbVie.
• Sebela Pharmaceuticals, Inc.
• Takeda Pharmaceutical Company Limited
• Alfasigma S.p.A.
• Astellas Pharma Inc.
• AstraZeneca
• Synthetic Biologics, Inc.
• Bausch + Lomb Incorporated
• Lannett Company Inc
Regional Assessment:
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the Irritable Bowel Syndrome (IBS) Treatment market based on various segments. It also provides market size and forecast estimates from year 2021 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Irritable Bowel Syndrome (IBS) Treatment market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
Feel Free to Ask Your Queries At - https://www.theinsightpartners.com/speak-to-analyst/TIPRE00006814/?utm_source=OpenPR&utm_medium=10741
The report segments global irritable bowel syndrome (IBS) treatment market as Follows:
By Type
• IBS with Diarrhea (IBS-D)
• IBS with Constipation (IBS-C)
• Mixed IBS (IBS-M)
By Product
• Rifaximin
• Eluxadoline
• Linaclotide
• Lubiprostone
• Others
By Distribution Channel
• Hospitals Pharmacies
• Drug Stores and Retail Pharmacies
• Online Pharmacies
This Irritable Bowel Syndrome (IBS) Treatment Report Provides a superior market perspective in terms of product trends, marketing strategy, future products, new geographical markets, future events, sales strategies, customer actions or behaviors. This market research study presents actionable market insights with which sustainable and money-spinning business strategies can be created.
Interested In Purchasing This Report? Click Here At - https://www.theinsightpartners.com/buy/TIPRE00006814/?utm_source=OpenPR&utm_medium=10741
The essential aspects like the latest market dynamics, development trends, and growth opportunities are presented, along with industry barriers, developmental threats, and risk factors. The report provides a concise market view that will provide ease of understanding. Also, the study presents the analytical depiction of the global market industry with the current and future estimations of the market.
If you have any queries about this report or if you would like further information, please contact us:
Contact Person: Sameer Joshi
E-mail: sales@theinsightpartners.com
Phone: +1-646-491-9876
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defence, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Irritable Bowel Syndrome (IBS) Treatment Market Analysis 2021 Global Insights, Industry Demand, Size, Type, Application, Trends, Outlook 2028 here
News-ID: 3066234 • Views: …
More Releases from The Insight Partners
Global Modular Connectors Market Poised for Strong Growth Driven by Telecommunic …
New York - USA, November 7, 2025 -The global Modular Connectors Market is witnessing significant momentum, propelled by rapid digitalization, increasing data transfer needs, and the accelerating adoption of smart technologies across industries. Modular connectors-commonly known for their adaptability, reliability, and ease of installation-are now integral to advanced networking, industrial automation, consumer electronics, and telecommunications infrastructure.
Market players are increasingly investing in product innovation to enhance performance, miniaturization, and durability, aligning…
Innovative Solutions and Rising Demand Propel Global Peritoneal Dialysis Equipme …
New York - USA, November 7, 2025 - The global peritoneal dialysis (PD) equipment market is experiencing robust expansion as patient preference for home-based renal care, advancements in PD technology, and growing incidence of chronic kidney disease (CKD) converge to reshape renal replacement therapy. Market analysts report rising adoption of automated peritoneal dialysis (APD) systems, portable cyclers, and single-use consumables - trends that are enhancing patient convenience, safety, and clinical…
Refrigerant Market is Predicted To Increase At A High-Value CAGR Of 6.5% By 2028
Global Refrigerant Market 2028 Report give our customers an exhaustive and top to bottom examination of Refrigerant Market alongside its key factors, for example, market diagram and rundown, pieces of the pie, restrictions, drivers, local examination, players, serious elements, division, and considerably more. The Refrigerant Market information introduced inside this report is acquired dependent on a few strategies, for example, PESTLE, Porter's Five, SWOT examination,
To Get PDF Sample Copy…
Bulk Molding Compound (BMC) Market is Grow at a CAGR of 4.6% to reach US$ 1,650. …
Global Bulk Molding Compound (BMC) Market 2027 Report give our customers an exhaustive and top to bottom examination of Bulk Molding Compound (BMC) Market alongside its key factors, for example, market diagram and rundown, pieces of the pie, restrictions, drivers, local examination, players, serious elements, division, and considerably more. The Bulk Molding Compound (BMC) Market information introduced inside this report is acquired dependent on a few strategies, for example, PESTLE,…
More Releases for IBS
Irritable Bowel Syndrome (IBS) Treatment Market Poised to Hit $7.68B by 2033 | S …
The Global Irritable Bowel Syndrome (IBS) Treatment Market reached US $3.61 billion in 2024 and is forecast to nearly double to US $7.68 billion by 2033, growing at a robust 8.8% CAGR from 2025 to 2033, according to DataM Intelligence's comprehensive report. IBS affects an estimated 5-10% of the global population, marking it one of the most prevalent gastrointestinal disorders with significant unmet medical needs.
👉 Download our latest market insights:…
IBS Implant Market Research Report 2023 - Valuates reports
The global IBS Implant market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes.
Get Sample report - https://reports.valuates.com/request/sample/QYRE-Auto-35O11417/Global_IBS_Implant_Market_Research_Report_2022
North American market for IBS Implant is estimated to increase from $ million in 2023 to reach $ million by 2029, at…
Integrated Bridge Systems Market Report 2018: Segmentation by Platform (Commerci …
Global Integrated Bridge Systems market research report provides company profile for Northrop Grumman Sperry Marine (U.K.), Raytheon Anschütz (Germany), Rolls Royce (U.K.), L-3 Communications Mapps Inc. (Canada), FURUNO Electric Shokai Ltd. (Japan) and Others.
This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue, YOY growth rate, and CAGR…
IBS' solution to power China’s first Cruise Line
Trivandrum, 16 January 2013: Henna, the largest cruise ship in mainland China will run on IBS’ inventory and pricing management solution, Cruise Partner, when it makes its maiden journey on January 26, 2013. China based HNA Tourism Cruise and Yacht Management Company unveiled this cruise ship on November 28, 2012. Henna has 739 rooms for 1,965 passengers, as well as a complete range of facilities for living and entertainment. HNA…
Vikash Sureka joins IBS as Chief Financial Officer
Trivandrum (India), 17 May 2012: IBS Software Services, the leading provider of new-generation IT solutions to the global aviation industry, has appointed Mr Vikash Sureka as its Chief Financial Officer. He will head the Finance, Legal, Company Affairs and Administration functions of IBS operations world-wide.
A Chartered Accountant, Vikash has over 19 years of experience mostly in senior executive roles managing business globally with proven proficiency in Investor Relations, P&L…
Raytheon Anschütz IBS for new Intership Bulkers
Raytheon Anschütz was recently awarded a contract to supply their Integrated Bridge System (IBS) to two new bulk carriers. The bulkers will be built at New Times Shipyard in Jingjiang, China. The delivery to the Cyprus based shipping company Intership Navigation Co. Ltd., a member of the German Hartmann Group, is scheduled for August and October 2011.
The new bulkers, each with a capacity of 176,000 dwt, will be equipped…
